针对性双重微滴用于调节骨质细胞分化和功能:一种新的治疗方法来对抗骨质疏松症
Maobiao Shi1, Jin Feng2, Ping Chen1
1Department of Orthopaedic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, China.
ACS applied materials & interfaces
|April 4, 2025
概括
新的超声响应微滴向骨质疏松症的关键因素,激活T细胞细胞质细胞1 (NFATc1) 的核因子和甲素K (CTSK). 这些双重微滴有效地降低了骨质细胞的活性,并保护大鼠模型的骨质损失.
科学领域:
- 生物材料科学 生物材料科学
- 细胞生物学 细胞生物学
- 整形外科 整形外科 整形外科
背景情况:
- 骨质疏松症是一个重要的全球健康问题,其特点是由于骨质细胞过度活动而导致的骨质损失.
- 激活T细胞细胞质1 (NFATc1) 的核因子对于早期骨质细胞分化至关重要,而甲素K (CTSK) 对于成熟的骨质细胞骨再吸收至关重要.
研究的目的:
- 开发和评估针对骨质疏松症治疗的NFATc1和CTSK的超声响应微滴 (MDs).
- 评估双重MDs在调节骨质细胞形成和预防骨质损失方面的有效性.
主要方法:
- 制造针对NFATc1和CTSK的双重超声响应微滴.
- 在hBMSCs和RAW 264.7巨细胞中评估细胞吸收和生物相容性.
- 在体外评估对骨质生成和骨质细胞生成的影响.
- 在卵巢切除的骨质疏松性大鼠模型中的体内研究.
主要成果:
- 双重MD显示了核心结构,高效的细胞吸收和最小的细胞毒性.
- 双重MDs对hBMSCs的骨质分化产生了最小的影响.
- 在体外,双重MDs协同抑制了骨质细胞的分化和形成.
- 在体内,双重MD显著保护了大鼠的卵巢切除诱导的骨损失.
结论:
- 双微小滴代表了对骨质疏松症的有希望的有针对性的治疗策略.
- 针对骨质细胞形成的早期和晚期阶段提供了一种协同方法来对抗骨质损失.
更多相关视频
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.6K
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
12.8K
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Remodeling
38.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.0K
